Millipore Corporation exchanges common stock with Merck

NewsGuard 100/100 Score

Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that Merck KGaA ("Merck") has completed its acquisition of Millipore (the "Acquisition") as of July 14, 2010. As part of the transaction, all issued and outstanding shares of Millipore common stock were exchanged for $107 per share in cash.

Millipore is delivering a notice to holders of its 3.75% Convertible Senior Notes Due 2026 (the "Notes"), pursuant to the indenture under which the Notes were issued (the "Indenture"), that the effective date of the Make-Whole Fundamental Change (as defined in the Indenture) was July 14, 2010 and that completion of the Acquisition triggered an increase in the Conversion Rate applicable to Notes surrendered for conversion during the Make-Whole Conversion Period.

As a result of the Make-Whole Fundamental Change described above, the Conversion Rate applicable to Notes that are surrendered for conversion during the Make-Whole Convertibility Period will be increased pursuant to Section 10.14 of the Indenture. The Make-Whole Applicable Increase (as defined in the Indenture) is 0.7519 Shares per $1,000 principal amount of Notes, which will result in an additional cash payment of $80.46 per $1,000 principal amount of Notes. In order to receive the increased Conversion Rate set forth above, Holders must surrender their Notes for conversion during the Make-Whole Conversion Period.

The Make-Whole Conversion Period during which Holders may surrender Notes for conversion at any time began on, and included June 14, 2010, the date that was 30 calendar days prior to the date originally announced by the Company as the anticipated Share Exchange Effective Time; and ends on, the later of (i) August 25, 2010, the date that is thirty (30) Business Days after the actual Share Exchange Effective Time which was July 14, 2010; and (ii) the "Fundamental Change Repurchase Date," which the Company will announce within twenty (20) Business Days after consummation of the Share Exchange.

Holders of notes should read carefully the notice being sent to Holders regarding their conversion rights and their right to require Millipore to repurchase their Notes in connection with the Make-Whole Fundamental Change, as it contains important information as to the procedures and timing for the exercise of such rights.

Source : Millipore Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production